

Gil J.  Van Lunsen: Executive Profile & Biography - Bloomberg









































  





















































































July 21, 2017 1:54 PM ET
Biotechnology

Company Overview of Array BioPharma Inc.



SnapshotPeople 




OverviewBoard MembersCommittees



Executive Profile
Gil J.  Van Lunsen  Director, Array BioPharma Inc.AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 8 different industries.See Board Relationships75$153,293
Background

		Mr. Gil J. Van Lunsen served as Managing Partner of KPMG LLP and led its Tulsa, Oklahoma office, since 1994. Mr. Van Lunsen retired from KPMG LLP in June 2000 following 32 years of service. Nine years after joining KPMG in 1968 as an Assistant Accountant, he became Partner and subsequently was promoted to Partner in charge of national accounting and audit training. He transferred to the Tulsa Oklahoma office in July 1980. He served as the Chairman of the Board of Trustees ... of both the Children's Medical Center and Tulsa Regional Medical Center in Tulsa. He has been a Director of Array BioPharma Inc. since October 2002. He serves as a Director of Northern Border Partners LP and Viking Gas Transmission Company. He has been an Independent Director of M/A-Com Technology Solutions Holdings, Inc. and M/A-COM Technology Solutions Inc. since August 2010. He was elected to the partnership in 1977. He has been an Independent Director of MACOM Technology Solutions Inc. and MACom Technology Solutions Holdings, Inc. since August 2010. He served as a Director Oneok Partners GP LLC, General Partner of ONEOK Partners, L.P. from May 2006 to April 11, 2015. Van Lunsen served as a Director at Sirenza Microdevices Inc. since October 16, 2003, ONEOK Inc. since April 2015, Hillcrest Healthcare Systems from July 2000 to March 2005 and VL Dissolution Corp. since June 1, 2001. Additionally, he was a Member of the Ethics Compliance Committee of Tyson Foods, Inc. from January 1997 to December 2002. He served as the Chairman of Audit Committee at both Hillcrest Healthcare System in Tulsa, Oklahoma and Vari L Company, Inc. in Denver, Colorado. His professional affiliations include the American Institute of Certified Public Accountants and the Colorado Society of Certified Public Accountants. Mr. Van Lunsen received his BS/BA in Accounting and Finance from the University of Denver in 1968 and is a Certified Public Accountant.Read Full Background




Corporate Headquarters
3200 Walnut StreetBoulder, Colorado 80301United StatesPhone: 303-381-6600Fax: --
Board Members Memberships
DirectorViking Gas Transmission Company2002-PresentDirectorArray BioPharma Inc.2010-PresentIndependent DirectorM/A-COM Technology Solutions Inc.2010-PresentIndependent DirectorMACOM Technology Solutions Holdings, Inc.
Education
BSBA 1968University of Denver
Other Affiliations
Sirenza Microdevices Inc.KPMG LLPM/A-COM Technology Solutions Inc.ONEOK, Inc.ONEOK Partners, L.P.VL Dissolution Corp.Viking Gas Transmission CompanyONEOK Partners GP, L.L.CUniversity of DenverMACOM Technology Solutions Holdings, Inc.


Annual Compensation
				There is no Annual Compensation data available.
				Stocks Options
				There is no Stock Options data available.
				Total Compensation
Total Annual Cash Compensation$62,250Total Calculated Compensation$153,293




Request Profile Update
















 












The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking 
	here.




Stock Quotes


Market data is delayed at least 15 minutes.







Company Lookup



COMPETITOR COMPENSATIONNamePosition/CompanyCompensationAmit D. Munshi President, CEO & DirectorArena Pharmaceuticals, Inc.$397.8KRobert I. Blum President, CEO & DirectorCytokinetics, Incorporated$941.7KJosé María  Fernández Sousa-Faro Ph.D.Founder, Executive Chairman, Chief Executive Officer and PresidentPharma Mar, S.A.$214.0KRajesh C. Shrotriya M.D.Chairman and Chief Executive OfficerSpectrum Pharmaceuticals, Inc.$1.9MMark R. Baker J.D.Chief Executive Officer and DirectorProgenics Pharmaceuticals, Inc.$646.8KCompensation as of Fiscal Year 2016.










Sponsored Financial Commentaries

Sponsored Links






Browse Companies
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 | 
0
1
2
3
4
5
6
7
8
9






Request Profile Update

						Only a company representative may request an update for the company profile. Documentation will be required.
					  
To contact Array BioPharma Inc., please visit .  Company data is provided by S&P Global Market Intelligence.  Please use this form to report any data issues.
					  


Information Missing - Please enter your information in the following field(s): 




Company Name

Your Name*

Your E-Mail Address*

Your Phone Number*

Type of Data*


Overview
Executives
Key developments
Similar companies
Transactions


Update Needed*

All data changes require verification from public sources.  Please include the correct value or values and a source where we can verify.


Cancel


Submit






Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.


Close


























Gil J. Van Lunsen, Board Dir., Array Biopharma Inc.














A publisher of Business Information since 1983   
  





 


   

Search Business Search Executive 
  Advanced Search 




  

Sign In  |  Hints 









Profile of Gil Van Lunsen 





 


Gil Van Lunsen

 

Board Dir. - Array Biopharma Inc.

 


Gil Van Lunsen Email :
Please login 

 

Company Name : 
Array Biopharma Inc. 

 

Company Website : 
www.arraybiopharma.com 

 

Company Address : 
3200 Walnut St., Boulder, CO,United States, 


 


Gil Van Lunsen Profile :
Board Dir. - Array Biopharma Inc. 

 


Gil Van Lunsen Biography :


Mr. Van Lunsen has served as a member of our Board of Directors since October 2002. Prior to his retirement in June 2000, Mr. Van Lunsen was a Managing Partner of KPMG LLP and led the firm�s Tulsa, Oklahoma office. During his 33-year career, Mr. Van Lunsen held various positions of increasing responsibility with KPMG and was elected to the partnership in 1977. Mr. Van Lunsen is currently the Audit Committee Chairman at both Hillcrest Healthcare System in Tulsa, Oklahoma and Sirenza Microdevices, Inc. in Broomfield, Colorado. Additionally, Mr. Van Lunsen was a member on the Ethics Compliance Committee for Tyson Foods, Inc. from 1997 until 2002, and chaired the Audit Committee of VariL Company, Inc. from 2001 until 2003. Mr. Van Lunsen received a B.S./B.A. in Accounting from the University of Denver and is a Certified Public Accountant.As part of his responsibilities as an Array Board member, Mr. Van Lunsen serves on Array's Audit Committee. 

 


Gil Van Lunsen Colleagues :





Name 
Title 
Email 


David Snitman 
Dir., COO, VP - Business Development 
Please login 


John Josey 
VP - Discovery Chemistry 
Please login 


Kyle Lefkoff 
Chmn. 
Please login 


Kevin Koch 
Dir., Pres., Chief Scientific Officer 
Please login 


Marvin Caruthers 
Board Dir. 
Please login 













            Home  |  About Us  |  Product Information   |  Subscription  |  List Builder   |  Executive List   |  Email Lists   |  Contact Us  |  Site Map  |  Browse Directory    





 

� 2009, Walkers's Research - A publisher of Business Information since 1983, All Rights Reserved.






MTSI Gil J. van Lunsen Insider Trades for MACOM Technology Solutions Holdings Inc.


































Bulletin






Investor Alert







New York Markets Close in:



Market Snapshot
Winners and Losers


















Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close































MACOM Technology Solutions Holdings Inc.

                  NASDAQ: MTSI
          



GO



Set Alerts
Find a Broker




Join TD Ameritrade




Market Index


 

Overview
      
Profile
      
News
      
Charts
      
Financials
      
Historical Quotes
      
Analyst Estimates
      
Options
      
SEC Filings
      
Insiders
      


/marketstate/country/us

MACOM Technology Solutions Holdings Inc.



Market open
 --Real time quotes
Jul 21, 2017, 1:53 p.m.


MTSI

/quotes/zigman/9131624/composite


$
62.85




Change

+0.12
+0.19%

Volume
Volume 288,116
Real time quotes








/quotes/zigman/9131624/composite
Previous close

$
			62.73
		


$
				62.85
			
Change

+0.12
+0.19%





Day low
Day high
$61.99
$63.46










52 week low
52 week high

            $35.33
        

            $63.46
        


















Insider Activity


Individual




Gil J. van Lunsen



Mr. Gil J. van Lunsen, CPA, is on the Board of Directors at MACOM Technology Solutions Holdings, Inc. and Array BioPharma, Inc. Mr. van Lunsen was previously employed as an Independent Director by ONEOK Partners LP, Managing Partner by KPMG LLP, an Independent Director by ONEOK Partners GP LLC, and Member-Ethics Compliance Committee by Tyson Foods, Inc. He also served on the board at Sirenza Microdevices, Inc. and Hillcrest Healthcare System, Inc. He received his undergraduate degree from the University of Denver.



Transactions


Date
Shares
Transaction
Value





05/23/2017
2,000


 
Disposition at $60.01 per share.


120,020


04/11/2017
962


 
Disposition at $50.85 per share.


48,918


03/14/2017
1,000


 
Disposition at $46.05 per share.


46,050


03/03/2017
2,835


 
Award at $0 per share.


0


02/14/2017
1,000


 
Disposition at $45.47 per share.


45,470


01/17/2017
1,000


 
Disposition at $46.83 per share.


46,830


12/13/2016
1,000


 
Disposition at $49.13 per share.


49,130


11/15/2016
1,000


 
Disposition at $40.69 per share.


40,690


10/11/2016
1,000


 
Disposition at $42.17 per share.


42,170


09/13/2016
1,000


 
Disposition at $41.06 per share.


41,060


08/22/2016
1,000


 
Disposition at $40 per share.


40,000


07/28/2016
2,000


 
Disposition at $40 per share.


80,000


03/04/2016
3,113


 
Award at $0 per share.


0


05/15/2015
1,577


 
Award at $0 per share.


0


01/21/2015
1,562


 
Award at $0 per share.


0


02/28/2014
2,970


 
Award at $0 per share.


0


11/18/2013
1,377


 
Award at $0 per share.


0


01/22/2013
3,355


 
Award at $0 per share.


0


11/02/2012
831


 
Award at $0 per share.


0





        Copyright 2017 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
    











            Officers and Executives
        





Mr. John L. Ocampo 
Chairman




Mr. John R. Croteau 
President, Chief Executive Officer & Director




Mr. Robert  Dennehy 
Senior Vice President-Operations




Mr. Robert J. McMullan 
CFO, Principal Accounting Officer & Senior VP




Dr. Douglas J Carlson 
Vice President-Technology




Dr. Alex A. Behfar 
SVP & General Manager-Photonic Solutions




Mr. Preetinder S.  Virk 
Senior Vice President & GM-Carrier Networks




Mr. Greg  Baker 
Senior Vice President, GM-RF & Microwave




Mr. Jack  Kennedy 
Senior Vice President, GM-Aerospace & Defense




Ms. Susan M. Ocampo 
Director




Mr. Dong Hyun  Hwang 
Senior Vice President-Global Sales




Mr. William Van Anglen 
Vice President-Human Resources




Mr. Clay  Simpson 
Secretary, Vice President & General Counsel




Mr. Geoffrey G. Ribar 
Independent Director




Mr. Charles R. Bland 
Independent Director




Mr. Stephen G. Daly 
Independent Director




Mr. Gil J. van Lunsen 
Independent Director




Mr. Peter Y. Chung 
Independent Director









Trending Tickers


/quotes/zigman/17636479/composite VUZI+15.60%


/quotes/zigman/237947/composite JCP-5.83%


/quotes/zigman/59392505/composite NUGT-2.93%


/quotes/zigman/59386294/composite JNUG-5.94%


/quotes/zigman/65801738/composite TLT+1.11%


X




Powered by














Log In




1:54 PM EDT
July 21, 2017


/marketstate/country/us
New York

	Open


/marketstate/country/uk
London

	Closed


/marketstate/country/jp
Tokyo

	Closed





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
1:52pWhite House briefs reporters after Spicer quits as press secretary: live blog
1:49pGold marks highest settlement in a month, up over 2% for the week
1:48pSpicer says in a tweet he'll continue in job through August
1:43pAugust gold climbs $9.40, or 0.8%, to settle at $1,254.90/oz
1:43pGold prices end at highest level in a month, up over 2% for the week
1:42pHollywood is using movies to push social causes — and vice versa
1:36pEuropean stocks log worst daily drop in 3 weeks as euro rallies
1:35pOil drops to a 1-week low with OPEC output expected to rise
1:32pHome-security company ADT could go public by the end of the year
1:26pGE’s stock falls as Jeff Immelt’s 64th and last quarter is another disappointment
1:21pEuro rally has room to run if this pattern continues to hold true
1:16pSean Spicer just quit. Should you be next?
1:15pPetIQ shares soaring 32% in company's market debut 
1:11pAmazon’s foray into groceries means more mergers of food companies, experts say
1:11pFTSE 100 ends lower, but retains grip on weekly gain  
1:08pBaker Hughes data show U.S. oil-rig count down for first time in three weeks
1:07pStock market retreats as GE casts pall on earnings season 
1:07pPetIQ shares up 32% in company's market debut 
1:06pHoneywell upgraded to buy from hold at CFRA
1:05pSeptember WTI oil trades at $45.83/bbl vs. $45.75 before the rig data
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,565.62

-46.16
-0.21%





nasdaq

/quotes/zigman/12633936/realtime
6,380.34

-9.66
-0.15%





s&p 500

/quotes/zigman/3870025/realtime
2,470.13

-3.32
-0.13%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15

























































ARRY Gil J. van Lunsen Insider Trades for Array BioPharma Inc.


































Bulletin






Investor Alert







New York Markets Close in:



Market Snapshot
Winners and Losers


















Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close































Array BioPharma Inc.

                  NASDAQ: ARRY
          



GO



Set Alerts
Find a Broker




Join TD Ameritrade




Market Index


 

Overview
      
Profile
      
News
      
Charts
      
Financials
      
Historical Quotes
      
Analyst Estimates
      
Options
      
SEC Filings
      
Insiders
      


/marketstate/country/us

Array BioPharma Inc.



Market open
 --Real time quotes
Jul 21, 2017, 1:54 p.m.


ARRY

/quotes/zigman/84685/composite


$
8.17




Change

-0.22
-2.57%

Volume
Volume 1.26m
Real time quotes








/quotes/zigman/84685/composite
Previous close

$
			8.38
		


$
				8.17
			
Change

-0.22
-2.57%





Day low
Day high
$8.16
$8.49










52 week low
52 week high

            $3.10
        

            $13.40
        


















Insider Activity


Individual




Gil J. van Lunsen



Mr. Gil J. van Lunsen, CPA, is Independent Director at M/A-COM Technology Solutions Holdings, Inc. and Independent Director at Array BioPharma, Inc. He is on the Board of Directors at M/A-COM Technology Solutions Holdings, Inc. and Array BioPharma, Inc.
Mr. van Lunsen was previously employed as Independent Director by ONEOK Partners LP, Managing Partner by KPMG LLP, Independent Director by ONEOK Partners GP LLC, and a Member-Ethics Compliance Committee by Tyson Foods, Inc. He also served on the board at Sirenza Microdevices, Inc. and Hillcrest Healthcare System, Inc.
He received his undergraduate degree from the University of Denver.



Transactions


Date
Shares
Transaction
Value





10/29/2016
5,000


 
Derivative/Non-derivative trans. at $5.83 per share.


29,150





        Copyright 2017 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
    











            Officers and Executives
        





Mr. Ron  Squarer 
Chief Executive Officer & Director




Mr. Andrew R. Robbins 
Chief Operating Officer




Mr. Jason  Haddock 
Chief Financial Officer




Dr. Victor  Sandor 
Chief Medical Officer




Dr. Nicholas A. Saccomano 
Chief Scientific Officer




Ms. Shalini  Sharp 
Director




Ms. Tricia  Haugeto 
Director-Corporate Communications & IR




Ms. Kimberly  Pope 
Vice President-Human Resources




Mr. John R. Moore 
Secretary, Vice President & General Counsel




Mr. Kyle A. Lefkoff 
Chairman




Dr. Charles M. Baum 
Independent Director




Mr. John A. Orwin 
Independent Director




Dr. Gwen A. Fyfe 
Independent Director




Mr. Gil J. van Lunsen 
Independent Director









Trending Tickers


/quotes/zigman/17636479/composite VUZI+15.60%


/quotes/zigman/237947/composite JCP-5.83%


/quotes/zigman/59392505/composite NUGT-2.93%


/quotes/zigman/59386294/composite JNUG-5.94%


/quotes/zigman/65801738/composite TLT+1.11%


X




Powered by














Log In




1:54 PM EDT
July 21, 2017


/marketstate/country/us
New York

	Open


/marketstate/country/uk
London

	Closed


/marketstate/country/jp
Tokyo

	Closed





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
1:52pWhite House briefs reporters after Spicer quits as press secretary: live blog
1:49pGold marks highest settlement in a month, up over 2% for the week
1:48pSpicer says in a tweet he'll continue in job through August
1:43pAugust gold climbs $9.40, or 0.8%, to settle at $1,254.90/oz
1:43pGold prices end at highest level in a month, up over 2% for the week
1:42pHollywood is using movies to push social causes — and vice versa
1:36pEuropean stocks log worst daily drop in 3 weeks as euro rallies
1:35pOil drops to a 1-week low with OPEC output expected to rise
1:32pHome-security company ADT could go public by the end of the year
1:26pGE’s stock falls as Jeff Immelt’s 64th and last quarter is another disappointment
1:21pEuro rally has room to run if this pattern continues to hold true
1:16pSean Spicer just quit. Should you be next?
1:15pPetIQ shares soaring 32% in company's market debut 
1:11pAmazon’s foray into groceries means more mergers of food companies, experts say
1:11pFTSE 100 ends lower, but retains grip on weekly gain  
1:08pBaker Hughes data show U.S. oil-rig count down for first time in three weeks
1:07pStock market retreats as GE casts pall on earnings season 
1:07pPetIQ shares up 32% in company's market debut 
1:06pHoneywell upgraded to buy from hold at CFRA
1:05pSeptember WTI oil trades at $45.83/bbl vs. $45.75 before the rig data
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,565.62

-46.16
-0.21%





nasdaq

/quotes/zigman/12633936/realtime
6,380.34

-9.66
-0.15%





s&p 500

/quotes/zigman/3870025/realtime
2,470.13

-3.32
-0.13%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15

































































 




Gil Van Lunsen |  | Decypha

































Sign In
|
Welcome  Guest 









 







Regions

GCC
                                |
                                    Levant
                                |
                                    MENA
                                |
                                    North Africa




GCC

Bahrain
                            |
                            Kuwait
                            |
                            Oman
                            |
                            Qatar
                            |
                            Saudi Arabia
                            |
                            United Arab Emirates




Levant

Iraq
                            |
                            Jordan
                            |
                            Lebanon
                            |
                            Palestine




North Africa

Egypt
                            |
                            Libya
                            |
                            Morocco
                            |
                            Tunisia




Others

Iran
                            |
                            Turkey
                            |
                            United Kingdom
                            |
                            United States












Advanced Search















News






Markets






Companies






Research






Funds






Fixed Income






Money Markets






Commodities






FX






Economics






Analysis






More











Sign In
Membership
Customize Your Decypha
Logout
Welcome
Decypha Alerts












Home




People Profiles




People Profile



Gil Van Lunsen Profile














Full Name:

                                                    Gil Van Lunsen
                                                







Country:











Biography


                                                    Gil Van Lunsen has served as a director since August 2010. Prior to his retirement in June 2000, Mr. Van Lunsen was a Managing Partner of KPMG LLP and... 











Designations




Date
Designation
Entity
Entity Description
Country




2002


Array BioPharma, Inc.

--

--



2005


ONEOK Partners, L.P.

Energy

                                                United States




2011


M/A-COM Technology Solutions Holdings Inc

--

--









Check all the  individuals in 
Check The List






Request a Trial
















Title:*


Select
Mr
Mrs
Ms
Miss
Dr
Prof




First Name:*



Last Name:*



Job Title:*


Select
 Asset Managers
 Corporate Banks
 Investment Managers
 Wealth Managers
 Consultants & Advisors
 Legal Practioners
 Academics
 Hedge Funds
 Private Equity Analysts
 Traders
 Equity Research Analysts




Phone:*



Company:*




Email:*




Country:*


Select

                                                Afganistan
                                        

                                                Albania
                                        

                                                Algeria
                                        

                                                American Samoa
                                        

                                                Andorra
                                        

                                                Angola
                                        

                                                Anguilla
                                        

                                                Antarctica
                                        

                                                Antigua and Barbuda
                                        

                                                Argentina
                                        

                                                Armenia
                                        

                                                Aruba
                                        

                                                Australia
                                        

                                                Austria
                                        

                                                Azerbaijan
                                        

                                                Bahamas
                                        

                                                Bahrain
                                        

                                                Bangladesh
                                        

                                                Barbados
                                        

                                                Belarus
                                        

                                                Belgium
                                        

                                                Belize
                                        

                                                Benin
                                        

                                                Bermuda
                                        

                                                Bhutan
                                        

                                                Bolivia
                                        

                                                Bosnia and Herzegovina
                                        

                                                Botswana
                                        

                                                Bouvet Island
                                        

                                                Brazil
                                        

                                                British Indian Ocean Territory
                                        

                                                Brunei
                                        

                                                Bulgaria
                                        

                                                Burkina Faso
                                        

                                                Burundi
                                        

                                                Cambodia
                                        

                                                Cameroon
                                        

                                                Canada
                                        

                                                Cape Verde
                                        

                                                Cayman Islands
                                        

                                                Central African Republic
                                        

                                                Chad
                                        

                                                Chile
                                        

                                                China
                                        

                                                Christmas Island
                                        

                                                Cocos (Keeling) Islands
                                        

                                                Colombia
                                        

                                                Comoros
                                        

                                                Congo
                                        

                                                Cook Islands
                                        

                                                Costa Rica
                                        

                                                Cote D'Ivoire (Ivory Coast)
                                        

                                                Croatia (Hrvatska)
                                        

                                                Cuba
                                        

                                                Curacao
                                        

                                                Cyprus
                                        

                                                Czech Republic
                                        

                                                Czechoslovakia (former)
                                        

                                                Denmark
                                        

                                                Djibouti
                                        

                                                Dominica
                                        

                                                Dominican Republic
                                        

                                                East Timor
                                        

                                                Ecuador
                                        

                                                Egypt
                                        

                                                El Salvador
                                        

                                                Equatorial Guinea
                                        

                                                Eritrea
                                        

                                                Estonia
                                        

                                                Ethiopia
                                        

                                                Falkland Islands (Malvinas)
                                        

                                                Faroe Islands
                                        

                                                Fiji
                                        

                                                Finland
                                        

                                                France
                                        

                                                France, Metropolitan
                                        

                                                French Guiana
                                        

                                                French Polynesia
                                        

                                                French Southern Territories
                                        

                                                Gabon
                                        

                                                Gambia
                                        

                                                Georgia
                                        

                                                Germany
                                        

                                                Ghana
                                        

                                                Gibraltar
                                        

                                                Greece
                                        

                                                Greenland
                                        

                                                Grenada
                                        

                                                Guadeloupe
                                        

                                                Guam
                                        

                                                Guatemala
                                        

                                                Guernsey
                                        

                                                Guinea
                                        

                                                Guinea-Bissau
                                        

                                                Guyana
                                        

                                                Haiti
                                        

                                                Heard and McDonald Islands
                                        

                                                Honduras
                                        

                                                Hong Kong
                                        

                                                Hungary
                                        

                                                Iceland
                                        

                                                India
                                        

                                                Indonesia
                                        

                                                Iran
                                        

                                                Iraq
                                        

                                                Ireland
                                        

                                                Isle of Man
                                        

                                                Israel
                                        

                                                Italy
                                        

                                                Jamaica
                                        

                                                Japan
                                        

                                                Jersey
                                        

                                                Jordan
                                        

                                                Kazakhstan
                                        

                                                Kenya
                                        

                                                Kiribati
                                        

                                                Kuwait
                                        

                                                Kyrgyzstan
                                        

                                                Laos
                                        

                                                Latvia
                                        

                                                Lebanon
                                        

                                                Lesotho
                                        

                                                Liberia
                                        

                                                Libya
                                        

                                                Liechtenstein
                                        

                                                Lithuania
                                        

                                                Luxembourg
                                        

                                                Macau
                                        

                                                Macedonia
                                        

                                                Madagascar
                                        

                                                Malawi
                                        

                                                Malaysia
                                        

                                                Maldives
                                        

                                                Mali
                                        

                                                Malta
                                        

                                                Marshall Islands
                                        

                                                Martinique
                                        

                                                Mauritania
                                        

                                                Mauritius
                                        

                                                Mayotte
                                        

                                                Mexico
                                        

                                                Micronesia
                                        

                                                Moldova
                                        

                                                Monaco
                                        

                                                Mongolia
                                        

                                                Montenegro
                                        

                                                Montserrat
                                        

                                                Morocco
                                        

                                                Mozambique
                                        

                                                Myanmar
                                        

                                                Namibia
                                        

                                                Nauru
                                        

                                                Nepal
                                        

                                                Netherlands
                                        

                                                Netherlands Antilles
                                        

                                                Neutral Zone
                                        

                                                New Caledonia
                                        

                                                New Zealand (Aotearoa)
                                        

                                                Nicaragua
                                        

                                                Niger
                                        

                                                Nigeria
                                        

                                                Niue
                                        

                                                Norfolk Island
                                        

                                                North Korea
                                        

                                                Northern Mariana Islands
                                        

                                                Norway
                                        

                                                Oman
                                        

                                                Pakistan
                                        

                                                Palau
                                        

                                                Palestine
                                        

                                                Panama
                                        

                                                Papua New Guinea
                                        

                                                Paraguay
                                        

                                                Peru
                                        

                                                Philippines
                                        

                                                Pitcairn
                                        

                                                Poland
                                        

                                                Portugal
                                        

                                                Puerto Rico
                                        

                                                Qatar
                                        

                                                Reunion
                                        

                                                Romania
                                        

                                                Russia
                                        

                                                Rwanda
                                        

                                                S. Georgia and S. Sandwich Isls.
                                        

                                                Saint Kitts and Nevis
                                        

                                                Saint Lucia
                                        

                                                Saint Vincent and the Grenadines
                                        

                                                Samoa
                                        

                                                San Marino
                                        

                                                Sao Tome and Principe
                                        

                                                Saudi Arabia
                                        

                                                Senegal
                                        

                                                Serbia
                                        

                                                Seychelles
                                        

                                                Sierra Leone
                                        

                                                Singapore
                                        

                                                Slovak Republic
                                        

                                                Slovenia
                                        

                                                Solomon Islands
                                        

                                                Somalia
                                        

                                                South Africa
                                        

                                                South Korea
                                        

                                                South Sudan
                                        

                                                Spain
                                        

                                                Sri Lanka
                                        

                                                St. Helena
                                        

                                                St. Pierre and Miquelon
                                        

                                                Sudan
                                        

                                                Suriname
                                        

                                                Svalbard and Jan Mayen Islands
                                        

                                                Swaziland
                                        

                                                Sweden
                                        

                                                Switzerland
                                        

                                                Syria
                                        

                                                Taiwan
                                        

                                                Tajikistan
                                        

                                                Tanzania
                                        

                                                Thailand
                                        

                                                Togo
                                        

                                                Tokelau
                                        

                                                Tonga
                                        

                                                Trinidad and Tobago
                                        

                                                Tunisia
                                        

                                                Turkey
                                        

                                                Turkmenistan
                                        

                                                Turks and Caicos Islands
                                        

                                                Tuvalu
                                        

                                                US Minor Outlying Islands
                                        

                                                USSR (former)
                                        

                                                Uganda
                                        

                                                Ukraine
                                        

                                                United Arab Emirates
                                        

                                                United Kingdom
                                        

                                                United States
                                        

                                                Uruguay
                                        

                                                Uzbekistan
                                        

                                                Vanuatu
                                        

                                                Vatican City State (Holy See)
                                        

                                                Venezuela
                                        

                                                Vietnam
                                        

                                                Virgin Islands (British)
                                        

                                                Virgin Islands (U.S.)
                                        

                                                Wallis and Futuna Islands
                                        

                                                Western Sahara
                                        

                                                Yemen
                                        

                                                Yugoslavia
                                        

                                                Zaire
                                        

                                                Zambia
                                        

                                                Zimbabwe
                                        




Comments:





*Required Fields


 

 Submit








Already Registered?








Login attempt was not successful. Please try again








Username/ Email:



Password:





Enter Characters:















 

 Login





 Forget your password?
























By Job Title


Asset Managers |
                                    Corporate Banks |
                                    Investment Managers |
                                    Wealth Managers |
                                    Consultants & Advisors |
                                    Legal Practitioners |
                                    Academics |
                                    Hedge Funds |
                                    Private Equity Analysts |
                                    Traders |
                                    Equity Research Analysts


By Scope


Equity |
                                    Fixed Income |
                                    Funds |
                                    Excel  |
                                    Analytical Tools  |
                                    Markets  |
                                    Prices  |
                                    Money Market |
                                    News |
                                    Industry |
                                    IPOs |
                                    Mergers & Acquisitions |
                                    Commodities |
                                    Economics



Covered Countries and Exchanges

















Add Your Company | 
                                        Add Yourself | 
                                        Terms and Conditions | 
                                        Privacy Policy | 
                                        About DirectFN









Copyright ©  DirectFN. All Rights Reserved.











Data Not Available









Login











Login attempt was not successful. Please try again


Username/ Email:


Password:



Enter Characters:











 Forget your password?











Back to Top

Support & Feedback


Ask for free trial









Request a Trial
















Title:*


Mr
Mrs
Ms
Miss
Dr
Prof




First Name:*



Last Name:*



Email:*




Phone:*



Promo. Code:



Country:*


Select
Afganistan
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Cook Islands
Costa Rica
Cote D'Ivoire (Ivory Coast)
Croatia (Hrvatska)
Cuba
Curacao
Cyprus
Czech Republic
Czechoslovakia (former)
Denmark
Djibouti
Dominica
Dominican Republic
East Timor
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands (Malvinas)
Faroe Islands
Fiji
Finland
France
France, Metropolitan
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard and McDonald Islands
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Isle of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macau
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Moldova
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
Neutral Zone
New Caledonia
New Zealand (Aotearoa)
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North Korea
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestine
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Reunion
Romania
Russia
Rwanda
S. Georgia and S. Sandwich Isls.
Saint Kitts and Nevis
Saint Lucia
Saint Vincent and the Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovak Republic
Slovenia
Solomon Islands
Somalia
South Africa
South Korea
South Sudan
Spain
Sri Lanka
St. Helena
St. Pierre and Miquelon
Sudan
Suriname
Svalbard and Jan Mayen Islands
Swaziland
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Tanzania
Thailand
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
US Minor Outlying Islands
USSR (former)
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
Uzbekistan
Vanuatu
Vatican City State (Holy See)
Venezuela
Vietnam
Virgin Islands (British)
Virgin Islands (U.S.)
Wallis and Futuna Islands
Western Sahara
Yemen
Yugoslavia
Zaire
Zambia
Zimbabwe




Company:*



Job Title:


Select
 Academics
 Asset Managers
 Consultants & Advisors
 Corporate Banks
 Equity Research Analysts
 Hedge Funds
 Investment Managers
 Legal Practioners
 Private Equity Analysts
 Traders
 Wealth Managers




Comments:




*Required Fields


 

 Submit



















Contact Us












Hello ,Please use the below form for
                            Product support & feedback


Name :  *  


Email:  * 


Phone Number :  * 






Preferred contact method :
Email
Phone











Technical Support 24x7: +94 112 314900 / slhops@directfn.net
Your Account Manager is, , , 






















 Get a Decypha Membership to view this content..................







Get a Decypha Membership


 Get the membership of Decypha Premium Package to access more exciting features including advanced analytical tools and the Pro 10 package. Pro 10 is designed keeping active investors in mind and offers a flexible framework to view information and do analysis the way you desire.

All you need to access these valuable features is to click on the Get a membership button and submit your details to our sales team.















Upgrade your Membership


 Account is not entitled to view this information.

 Please contact your account manager to upgrade your Membership.

Email :  support@decypha.com






 Register to view this content..................







 Decypha Free Registration


Register free with Decypha and get access to real-time price information and many other features including Technical Scanner, Fundamental Screener etc.

Just click the Registration button, submit your details and get registered for free.








 










Gil J. Van Lunsen - Executive Bio, Compensation History, and Contacts - Equilar Atlas










 

















Log in | Sign up








x

 






As Featured In




















Gil J. Van Lunsen
Board Member at Array BioPharma Inc.


View Full Profile
Are you Gil J. Van Lunsen? Claim your profile


 


Sign up for Equilar Atlas and view Gil J. Van Lunsen's full profile. 
With Equilar Atlas, you can:



IDENTIFY corporate executives in Gil J. Van Lunsen's  network and community.
												FOLLOW changes in Gil J. Van Lunsen's employment and money-in-motion.
												CONNECT with Gil J. Van Lunsen through your network of contacts.
												








Gil J. Van Lunsen's Executive Work History


Current


Board Member, 
MACOM Technology Solutions Holdings, Inc.


Board Member, 
Array BioPharma Inc.


Past
To view Gil J. Van Lunsen's complete executive work history, sign up now
Education


														 B.S., 
															University of Denver


Age
74

 
 


Gil J. Van Lunsen's Biography



Gil Van Lunsen, age 74, is a Class I director who has served as a director since August 2010. Prior to his retirement in June 2000, Mr. Van Lunsen was a Managing Partner of KPMG LLP and led the firm's Tulsa, Oklahoma office. During his 33-year career, Mr. Van Lunsen held various positions of increasing responsibility with KPMG LLP and was elected partner in 1977. Mr. Van Lunsen is currently a member of the board of directors and the audit committee chairman at Array Biopharma Inc., a biopharmaceutical company. He served as a director and the chairman of the audit committee of ONEOK Partners, L.P., a natural gas gathering, processing, storage  ...
(Read More)

			Gil Van Lunsen, age 74, is a Class I director who has served as a director since August 2010. Prior to his retirement in June 2000, Mr. Van Lunsen was a Managing Partner of KPMG LLP and led the firm's Tulsa, Oklahoma office. During his 33-year career, Mr. Van Lunsen held various positions of increasing responsibility with KPMG LLP and was elected partner in 1977. Mr. Van Lunsen is currently a member of the board of directors and the audit committee chairman at Array Biopharma Inc., a biopharmaceutical company. He served as a director and the chairman of the audit committee of ONEOK Partners, L.P., a natural gas gathering, processing, storage and transportation provider and its predecessor entities from 2005 until his retirement in 2015. Previously, Mr. Van Lunsen served as a director of Sirenza and was chairman of its audit committee from October 2003 through its sale to RFMD in November 2007. Mr. Van Lunsen received a B.S./B.A. in accounting from the University of Denver. Mr. Van Lunsen has extensive experience with complex financial and accounting issues and, as a former partner of KPMG LLP and the audit committee chairman at other public companies in our industry and others, provides valuable leadership and insights to our board of directors on accounting, financial and governance matters. Having served as a director of Sirenza, Mr. Van Lunsen has also developed strong domain knowledge of the operational and financial issues facing our Company and our industry.
		
Source: MACOM Technology Solutions Holdings, Inc. on 09/12/2016
		
	

 






Sign up for Equilar Atlas and view Gil J. Van Lunsen's full profile. 



												By accessing Equilar Atlas, you can view bios, network, salary and wealth events
												of industry-leading executives like Gil J. Van Lunsen. More specifically, you'll be able to:
												

IDENTIFY corporate executives in Gil J. Van Lunsen's  network and community.
												FOLLOW changes in Gil J. Van Lunsen's employment and money-in-motion.
												CONNECT with Gil J. Van Lunsen through your network of conections.
												




View Full Profile


 








Search for over 360,000 executive profiles.





/bio



													Example: Gil J. Van Lunsen


















Gil J. Van Lunsen's Connections (84)





Sign up now to view Gil J. Van Lunsen's 84 connections »









Gerald B. Smith
Board Member, Eaton Corporation plc









Liam Ratcliffe
Former Board Member, Edge Therapeutics, Inc.









Ron Squarer
Dir. and Chief Executive Officer, Array BioPharma Inc.









R. M. Carruthers
Chief Financial Officer and Interim President, Nivalis Therapeutics, Inc.









David L. Snitman
Former Consultant, Array BioPharma Inc.









Michael N. Needle
Chief Medical Officer, AVEO Pharmaceuticals, Inc.









John A. Orwin
Dir., President and Chief Executive Officer, Relypsa, Inc.









John L. Zabriskie
Former Board Member, Array BioPharma Inc.









Caron A. Lawhorn
Senior Vice President, Commercial, ONE Gas, Inc.









Wesley J. Christensen
Senior Vice President, Operations, ONEOK, Inc.








Popular Profiles






														Sign up now to view more executive profiles »
														









John J. Kita
EVP and CFO, A. O. Smith









Elon R. Musk
CEO and Chairman, Tesla









Thomas J. Lynch
Executive Chairman, TE Connectivity Ltd.









Jan Koum
Board Member, Facebook, Inc.









Robert D. Perlmutter
Senior EVP and COO, The Macerich Company












×

Claim Your Profile Coming Soon
Interested in updating your biography and work history?
We're working on making it happen.
We'll email you when this feature is available.
Please enter valid email address.

Done


Thank you for your interest.
Ok






			Browse executive profiles:
			
				 A
			
				 B
			
				 C
			
				 D
			
				 E
			
				 F
			
				 G
			
				 H
			
				 I
			
				 J
			
				 K
			
				 L
			
				 M
			
				 N
			
				 O
			
				 P
			
				 Q
			
				 R
			
				 S
			
				 T
			
				 U
			
				 V
			
				 W
			
				 X
			
				 Y
			
				 Z



Equilar Homepage
Equilar Atlas
Equilar Insight
Equilar BoardEdge
Equilar Engage
Research Services
Knowledge Network
About Us
Login

� 2017 Equilar All Rights Reserved. Privacy Policy
1100 Marshall Street, Redwood City, CA 94063 | Phone (650) 241-6600 | Fax (650) 701-0993
















 SECGems: VAN LUNSEN GIL J 







































  







			Data feeds now available
			Excel / CSV / Java / Python /etc 
Database
Learn more









  




  


  






























 VAN LUNSEN GIL J 
		     










 Info




 Ownership




 Filings














←


 1 


 2 


 3 


→



 Ownership filings:    (1 of 20 - Total: 49)








Filing date
2017-05-25
Submission
 0000904454-17-000396.nc

Form
4  Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
Issuer
 MACOM Technology Solutions Holdings, Inc.  MTSI

Reporting Owner
 VAN LUNSEN GIL J
[
				      
				        Director,  
				      
				      
				      
				      
				      ]







Type
Title
Conv/Exer price
Trans. date
Deemed Exe date
Trans Form Type
Trans Code
Eqty swap?
Footnote id
Trans timelines
# Shares
Value
Total Value
Price / share
Acq or Disp
Date exercisable
Expiration date
# Owned post trans
Value Owned post trans
Underlying security title
# Underlying securities
Value underlying securities
Direct or Indirect own
Nature indirect own

Non-Derriv. transCommon Stock2017-05-234S : Open market or private saleFalse200060.01D14789D












Filing date
2017-04-13
Submission
 0000904454-17-000309.nc

Form
4  Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
Issuer
 MACOM Technology Solutions Holdings, Inc.  MTSI

Reporting Owner
 VAN LUNSEN GIL J
[
				      
				        Director,  
				      
				      
				      
				      
				      ]







Type
Title
Conv/Exer price
Trans. date
Deemed Exe date
Trans Form Type
Trans Code
Eqty swap?
Footnote id
Trans timelines
# Shares
Value
Total Value
Price / share
Acq or Disp
Date exercisable
Expiration date
# Owned post trans
Value Owned post trans
Underlying security title
# Underlying securities
Value underlying securities
Direct or Indirect own
Nature indirect own

Non-Derriv. transCommon Stock2017-04-114S : Open market or private saleFalse96250.85D16789D












Filing date
2017-03-16
Submission
 0000904454-17-000255.nc

Form
4  Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
Issuer
 MACOM Technology Solutions Holdings, Inc.  MTSI

Reporting Owner
 VAN LUNSEN GIL J
[
				      
				        Director,  
				      
				      
				      
				      
				      ]







Type
Title
Conv/Exer price
Trans. date
Deemed Exe date
Trans Form Type
Trans Code
Eqty swap?
Footnote id
Trans timelines
# Shares
Value
Total Value
Price / share
Acq or Disp
Date exercisable
Expiration date
# Owned post trans
Value Owned post trans
Underlying security title
# Underlying securities
Value underlying securities
Direct or Indirect own
Nature indirect own

Non-Derriv. transCommon Stock2017-03-144S : Open market or private saleFalse100046.05D17751D












Filing date
2017-03-07
Submission
 0000904454-17-000217.nc

Form
4  Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
Issuer
 MACOM Technology Solutions Holdings, Inc.  MTSI

Reporting Owner
 VAN LUNSEN GIL J
[
				      
				        Director,  
				      
				      
				      
				      
				      ]







Type
Title
Conv/Exer price
Trans. date
Deemed Exe date
Trans Form Type
Trans Code
Eqty swap?
Footnote id
Trans timelines
# Shares
Value
Total Value
Price / share
Acq or Disp
Date exercisable
Expiration date
# Owned post trans
Value Owned post trans
Underlying security title
# Underlying securities
Value underlying securities
Direct or Indirect own
Nature indirect own

Non-Derriv. transCommon Stock2017-03-034A : Grant / awardFalse28350A18751D












Filing date
2017-02-16
Submission
 0000904454-17-000201.nc

Form
4  Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
Issuer
 MACOM Technology Solutions Holdings, Inc.  MTSI

Reporting Owner
 VAN LUNSEN GIL J
[
				      
				        Director,  
				      
				      
				      
				      
				      ]







Type
Title
Conv/Exer price
Trans. date
Deemed Exe date
Trans Form Type
Trans Code
Eqty swap?
Footnote id
Trans timelines
# Shares
Value
Total Value
Price / share
Acq or Disp
Date exercisable
Expiration date
# Owned post trans
Value Owned post trans
Underlying security title
# Underlying securities
Value underlying securities
Direct or Indirect own
Nature indirect own

Non-Derriv. transCommon Stock2017-02-144S : Open market or private saleFalse100045.47D15916D












Filing date
2017-01-19
Submission
 0000904454-17-000057.nc

Form
4  Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
Issuer
 MACOM Technology Solutions Holdings, Inc.  MTSI

Reporting Owner
 VAN LUNSEN GIL J
[
				      
				        Director,  
				      
				      
				      
				      
				      ]







Type
Title
Conv/Exer price
Trans. date
Deemed Exe date
Trans Form Type
Trans Code
Eqty swap?
Footnote id
Trans timelines
# Shares
Value
Total Value
Price / share
Acq or Disp
Date exercisable
Expiration date
# Owned post trans
Value Owned post trans
Underlying security title
# Underlying securities
Value underlying securities
Direct or Indirect own
Nature indirect own

Non-Derriv. transCommon Stock2017-01-174S : Open market or private saleFalse100046.83D16916D












Filing date
2016-12-15
Submission
 0000904454-16-001611.nc

Form
4  Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
Issuer
 MACOM Technology Solutions Holdings, Inc.  MTSI

Reporting Owner
 VAN LUNSEN GIL J
[
				      
				        Director,  
				      
				      
				      
				      
				      ]







Type
Title
Conv/Exer price
Trans. date
Deemed Exe date
Trans Form Type
Trans Code
Eqty swap?
Footnote id
Trans timelines
# Shares
Value
Total Value
Price / share
Acq or Disp
Date exercisable
Expiration date
# Owned post trans
Value Owned post trans
Underlying security title
# Underlying securities
Value underlying securities
Direct or Indirect own
Nature indirect own

Non-Derriv. transCommon Stock2016-12-134S : Open market or private saleFalse100049.13D17916D












Filing date
2016-11-17
Submission
 0000904454-16-001578.nc

Form
4  Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
Issuer
 MACOM Technology Solutions Holdings, Inc.  MTSI

Reporting Owner
 VAN LUNSEN GIL J
[
				      
				        Director,  
				      
				      
				      
				      
				      ]







Type
Title
Conv/Exer price
Trans. date
Deemed Exe date
Trans Form Type
Trans Code
Eqty swap?
Footnote id
Trans timelines
# Shares
Value
Total Value
Price / share
Acq or Disp
Date exercisable
Expiration date
# Owned post trans
Value Owned post trans
Underlying security title
# Underlying securities
Value underlying securities
Direct or Indirect own
Nature indirect own

Non-Derriv. transCommon Stock2016-11-154S : Open market or private saleFalse100040.69D18916D












Filing date
2016-10-31
Submission
 0001562180-16-003303.nc

Form
4  Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
Issuer
 ARRAY BIOPHARMA INC  ARRY

Reporting Owner
 VAN LUNSEN GIL J
[
				      
				        Director,  
				      
				      
				      
				      
				      ]







Type
Title
Conv/Exer price
Trans. date
Deemed Exe date
Trans Form Type
Trans Code
Eqty swap?
Footnote id
Trans timelines
# Shares
Value
Total Value
Price / share
Acq or Disp
Date exercisable
Expiration date
# Owned post trans
Value Owned post trans
Underlying security title
# Underlying securities
Value underlying securities
Direct or Indirect own
Nature indirect own

Non-Derriv. transCommon Stock2016-10-294M : Exer. or conv. of deriv. security exemptedFalse5000.005.83A10260.00D
Derriv. transRestricted Stock Units0.002016-10-274A : Grant / awardFalse5000.000.00A2017-10-275000.00Common Stock5000.00D
Derriv. transStock Option (Right to Buy)5.952016-10-274A : Grant / awardFalse25000.000.00A2017-10-272026-10-2725000.00Common Stock25000.00D
Derriv. transRestricted Stock Units0.002016-10-294M : Exer. or conv. of deriv. security exemptedFalse5000.000.00D2016-10-290.00Common Stock5000.00D












Filing date
2016-10-13
Submission
 0000904454-16-001496.nc

Form
4  Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
Issuer
 MACOM Technology Solutions Holdings, Inc.  MTSI

Reporting Owner
 VAN LUNSEN GIL J
[
				      
				        Director,  
				      
				      
				      
				      
				      ]







Type
Title
Conv/Exer price
Trans. date
Deemed Exe date
Trans Form Type
Trans Code
Eqty swap?
Footnote id
Trans timelines
# Shares
Value
Total Value
Price / share
Acq or Disp
Date exercisable
Expiration date
# Owned post trans
Value Owned post trans
Underlying security title
# Underlying securities
Value underlying securities
Direct or Indirect own
Nature indirect own

Non-Derriv. transCommon Stock2016-10-114S : Open market or private saleFalse100042.17D19916D












Filing date
2016-09-15
Submission
 0000904454-16-001443.nc

Form
4  Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
Issuer
 MACOM Technology Solutions Holdings, Inc.  MTSI

Reporting Owner
 VAN LUNSEN GIL J
[
				      
				        Director,  
				      
				      
				      
				      
				      ]







Type
Title
Conv/Exer price
Trans. date
Deemed Exe date
Trans Form Type
Trans Code
Eqty swap?
Footnote id
Trans timelines
# Shares
Value
Total Value
Price / share
Acq or Disp
Date exercisable
Expiration date
# Owned post trans
Value Owned post trans
Underlying security title
# Underlying securities
Value underlying securities
Direct or Indirect own
Nature indirect own

Non-Derriv. transCommon Stock2016-09-134S : Open market or private saleFalse100041.06D20916D












Filing date
2016-08-24
Submission
 0000904454-16-001384.nc

Form
4  Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
Issuer
 MACOM Technology Solutions Holdings, Inc.  MTSI

Reporting Owner
 VAN LUNSEN GIL J
[
				      
				        Director,  
				      
				      
				      
				      
				      ]







Type
Title
Conv/Exer price
Trans. date
Deemed Exe date
Trans Form Type
Trans Code
Eqty swap?
Footnote id
Trans timelines
# Shares
Value
Total Value
Price / share
Acq or Disp
Date exercisable
Expiration date
# Owned post trans
Value Owned post trans
Underlying security title
# Underlying securities
Value underlying securities
Direct or Indirect own
Nature indirect own

Non-Derriv. transCommon Stock2016-08-224S : Open market or private saleFalse100040.00D21916D












Filing date
2016-08-01
Submission
 0000904454-16-001338.nc

Form
4  Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
Issuer
 MACOM Technology Solutions Holdings, Inc.  MTSI

Reporting Owner
 VAN LUNSEN GIL J
[
				      
				        Director,  
				      
				      
				      
				      
				      ]







Type
Title
Conv/Exer price
Trans. date
Deemed Exe date
Trans Form Type
Trans Code
Eqty swap?
Footnote id
Trans timelines
# Shares
Value
Total Value
Price / share
Acq or Disp
Date exercisable
Expiration date
# Owned post trans
Value Owned post trans
Underlying security title
# Underlying securities
Value underlying securities
Direct or Indirect own
Nature indirect own

Non-Derriv. transCommon Stock2016-07-284S : Open market or private saleFalse200040.00D22916D












Filing date
2016-03-08
Submission
 0000904454-16-001116.nc

Form
4  Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
Issuer
 M/A-COM Technology Solutions Holdings, Inc.  MTSI

Reporting Owner
 VAN LUNSEN GIL J
[
				      
				        Director,  
				      
				      
				      
				      
				      ]







Type
Title
Conv/Exer price
Trans. date
Deemed Exe date
Trans Form Type
Trans Code
Eqty swap?
Footnote id
Trans timelines
# Shares
Value
Total Value
Price / share
Acq or Disp
Date exercisable
Expiration date
# Owned post trans
Value Owned post trans
Underlying security title
# Underlying securities
Value underlying securities
Direct or Indirect own
Nature indirect own

Non-Derriv. transCommon Stock2016-03-044A : Grant / awardFalse31130A24916D












Filing date
2015-11-02
Submission
 0001562180-15-000941.nc

Form
4  Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
Issuer
 ARRAY BIOPHARMA INC  ARRY

Reporting Owner
 VAN LUNSEN GIL J
[
				      
				        Director,  
				      
				      
				      
				      
				      ]







Type
Title
Conv/Exer price
Trans. date
Deemed Exe date
Trans Form Type
Trans Code
Eqty swap?
Footnote id
Trans timelines
# Shares
Value
Total Value
Price / share
Acq or Disp
Date exercisable
Expiration date
# Owned post trans
Value Owned post trans
Underlying security title
# Underlying securities
Value underlying securities
Direct or Indirect own
Nature indirect own

Derriv. transRestricted Stock Units0.002015-10-294A : Grant / awardFalse5000.000.00A2016-10-295000.00Common Stock5000.00D
Derriv. transStock Option (Right to Buy)5.132015-10-294A : Grant / awardFalse25000.000.00A2016-10-292025-10-2925000.00Common Stock25000.00D












Filing date
2015-05-19
Submission
 0001181431-15-007186.nc

Form
4  Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
Issuer
 M/A-COM Technology Solutions Holdings, Inc.  MTSI

Reporting Owner
 VAN LUNSEN GIL J
[
				      
				        Director,  
				      
				      
				      
				      
				      ]







Type
Title
Conv/Exer price
Trans. date
Deemed Exe date
Trans Form Type
Trans Code
Eqty swap?
Footnote id
Trans timelines
# Shares
Value
Total Value
Price / share
Acq or Disp
Date exercisable
Expiration date
# Owned post trans
Value Owned post trans
Underlying security title
# Underlying securities
Value underlying securities
Direct or Indirect own
Nature indirect own

Non-Derriv. transCommon Stock2015-05-154A : Grant / awardFalse15770A21803D












Filing date
2015-01-23
Submission
 0001181431-15-001445.nc

Form
4  Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
Issuer
 M/A-COM Technology Solutions Holdings, Inc.  MTSI

Reporting Owner
 VAN LUNSEN GIL J
[
				      
				        Director,  
				      
				      
				      
				      
				      ]







Type
Title
Conv/Exer price
Trans. date
Deemed Exe date
Trans Form Type
Trans Code
Eqty swap?
Footnote id
Trans timelines
# Shares
Value
Total Value
Price / share
Acq or Disp
Date exercisable
Expiration date
# Owned post trans
Value Owned post trans
Underlying security title
# Underlying securities
Value underlying securities
Direct or Indirect own
Nature indirect own

Non-Derriv. transCommon Stock2015-01-214A : Grant / awardFalse15620A20226D












Filing date
2014-10-31
Submission
 0001127602-14-030697.nc

Form
4  Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
Issuer
 ARRAY BIOPHARMA INC  ARRY

Reporting Owner
 VAN LUNSEN GIL J
[
				      
				        Director,  
				      
				      
				      
				      
				      ]







Type
Title
Conv/Exer price
Trans. date
Deemed Exe date
Trans Form Type
Trans Code
Eqty swap?
Footnote id
Trans timelines
# Shares
Value
Total Value
Price / share
Acq or Disp
Date exercisable
Expiration date
# Owned post trans
Value Owned post trans
Underlying security title
# Underlying securities
Value underlying securities
Direct or Indirect own
Nature indirect own

Derriv. transStock Option (Right to Buy)3.872014-10-304A : Grant / awardFalse250000A2015-10-302024-10-3025000Common Stock25000D












Filing date
2014-03-04
Submission
 0001181431-14-010790.nc

Form
4  Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
Issuer
 M/A-COM Technology Solutions Holdings, Inc.  MTSI

Reporting Owner
 VAN LUNSEN GIL J
[
				      
				        Director,  
				      
				      
				      
				      
				      ]







Type
Title
Conv/Exer price
Trans. date
Deemed Exe date
Trans Form Type
Trans Code
Eqty swap?
Footnote id
Trans timelines
# Shares
Value
Total Value
Price / share
Acq or Disp
Date exercisable
Expiration date
# Owned post trans
Value Owned post trans
Underlying security title
# Underlying securities
Value underlying securities
Direct or Indirect own
Nature indirect own

Non-Derriv. transCommon Stock2014-02-284A : Grant / awardFalse29700A18664D












Filing date
2013-11-20
Submission
 0001181431-13-060021.nc

Form
4  Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
Issuer
 M/A-COM Technology Solutions Holdings, Inc.  MTSI

Reporting Owner
 VAN LUNSEN GIL J
[
				      
				        Director,  
				      
				      
				      
				      
				      ]







Type
Title
Conv/Exer price
Trans. date
Deemed Exe date
Trans Form Type
Trans Code
Eqty swap?
Footnote id
Trans timelines
# Shares
Value
Total Value
Price / share
Acq or Disp
Date exercisable
Expiration date
# Owned post trans
Value Owned post trans
Underlying security title
# Underlying securities
Value underlying securities
Direct or Indirect own
Nature indirect own

Non-Derriv. transCommon Stock2013-11-184A : Grant / awardFalse13770A15694D









←


 1 


 2 


 3 


→


 







db
 
 













































Committee Composition - MACOM Technology Solutions Holdings, Inc.


















































Home


News


About Us


Careers



    Investors



Partner Login


Contact


Quality


MyMACOM













































Find Products

RF Power Products

RF Power Transistors - GaN on Si


RF Power Transistors - Silicon Bipolar


RF Power Transistors - Silicon MOSFET


GaN and GaAs Device Bias Sequencer


RF Power - Silicon Bipolar Pallet and Modules


spotlight-component




Optoelectronics

Laser and Modulator Drivers


Transimpedance Amplifiers (TIAs)


Clock & Data Recovery


Optical Post Amplifiers


LED/Laser Drivers for Display




Photonic Solutions

Fabry-Perot Lasers


Distributed Feedback Lasers


Photonic Integrated Circuits (PICs)


Laser Photonic Integrated Circuits (L-PICâ„¢)




Optical Sub-Assemblies

Transmitter Optical Sub-Assembly (TOSA)


Receiver Optical Sub-Assembly (ROSA)




Amplifiers

Active Splitters


Amplifier Gain Blocks


CATV Amplifiers


Distributed Amplifiers


FTTx Amplifiers


Hybrid Amplifiers


Linear Amplifiers


Low Noise Amplifiers


Power Amplifiers


Variable Gain Amplifiers




Diodes

PIN Limiter Diodes


PIN Switch and Attenuator Diodes


Schottky Mixer and Detector Diodes


Multiplier Step Recovery Diodes


Varactor Tuning Diodes


Germanium Tunnel Diodes


DC Voltage Current Limiter




Crosspoints and Signal Conditioners

Crosspoint Switches, Signal Conditioners/Redrivers




SDI Products

SDI Cable Drivers


SDI Cable Equalizers


SDI Reclockers




Frequency Conversion

Frequency Multipliers


Hybrid Mixers


Mixers


Receivers


Transceivers


Up Converters




Control Products

CMOS Switch Drivers


Digital Attenuators


Digital Phase Shifters


IQ Modulators / Demodulators


Limiters


Power Detectors


Switches


Voltage Variable Attenuators


Phase Detectors




Passives

Bias Networks


Couplers


Filters / Diplexers


Power Dividers / Combiners


Transformers / Baluns


Resistor Products


Inductor Products


Capacitors




HDcctv Devices

HDcctv Cable Drivers


HDcctv Cable Equalizers


HDcctv Reclockers




Frequency Generation

Voltage Controlled Oscillators


NLTL GaAs Comb Generators




Communications Processors

Wide Area Networks


Voice (VoIP) Processors


Carrier Convergence Processors


Enterprise Voice and Data Processors




Hi-Rel Components

Current Regulators


Schottky Barrier Rectifier Chip Series


Silicon Switching Diodes


Ultrafast Rectifier Diodes


Zener Diode Chips


TC Zener Reference Diodes


Low Noise Zener Diode


Silicon Zener Diodes


Silicon Controlled Rectifiers


PNP Transistors


NPN Power Transistors


NPN RAD Hard Small Signal Transistors






View Applications

Wireless Networking and Communication

Wireless Network Infrastructure


Wireless Backhaul


Wireless LAN (WiFi)


SatCom/VSAT


5G Communications




Optical Networking

Data Center


Metro


Client Side


Line Side


FTTx




RF Energy

Automotive Ignition


Industrial Cooking


Industrial Drying


Medical Tumor Ablation


Plasma Street Lighting




Aerospace and Defense

Communication


EW


Radar


MACOM in Active Antennas


Space and Hi-Rel




Industrial, Scientific and Medical

Industrial


Test and Measurement


Healthcare




Wired Broadband

CATV Head-End


CATV HFC Infrastructure


CATV/Satellite Set Top Box


FTTx Infrastructure




Broadcast Video

Cameras


Distribution Amplifiers


Format Conversion


Monitors


Routers and Switchers




Enterprise Solutions

Backplane Connectivity


Packet Switchers and Routers


Storage Area Networks


Transport Networks/OTN




Surveillance

Cameras


DVRs






Make Purchases


Explore Technologies

Gallium Nitride (GaN)



Silicon Photonics (SiPh)


Silicon Germanium (SiGe)


Aluminium Gallium Arsenide (AlGaAs)


Indium Phosphide (InP)


Gallium Arsenide (GaAs)


Silicon (Si)


Heterolithic Microwave Integrated Circuit (HMIC)


Self Aligning Etched Facet Technology




Get Support

Training


RF & Microwave Product Selection Guide


Contact Us



Key Markets & Products Brochure


Technical Resources Library


Optoelectronics & Photonics Portfolio


High Power GaN Portfolio


SDI Video Portfolio


Diodes Portfolio


Space & High-Reliability Portfolio



























Committee Composition

Show all 



John Ocampo
Chairman





John Ocampo has served as a director and as the Chairman of the board of directors since our inception in March 2009. Mr. Ocampo has also served as President of GaAs Labs since co-founding it in February 2008. Previously, Mr. Ocampo co-founded Sirenza in 1984, served as a director of Sirenza from its inception in 1984 through its sale to RFMD in November 2007, and served in a number of senior executive roles throughout that period, most recently as its Chairman from December 1998 through November 2007. Mr. Ocampo also served as a director of RFMD from November 2007 to November 2008. From October 2010 to October 2013, Mr. Ocampo served as a director of Ubiquiti Networks, Inc. (“Ubiquiti”), a developer of networking technology for service providers and enterprises. Mr. Ocampo also serves as a director of various privately-held companies. Mr. Ocampo holds a B.S.E.E. from Santa Clara University. Mr. Ocampo’s strategic vision, developed over more than 30 years successfully leading public and private companies in the RF semiconductor and component industry, is a unique asset to our board of directors. His engineering background and extensive knowledge of our operations, markets and technology provides our board of directors with important insights. We also believe that having our largest stockholder (together with Mrs. Ocampo and their affiliates) on the board of directors assists the board in making decisions aimed at increasing stockholder value over the long term.





John Croteau
President & Chief Executive Officer and Director 





John Croteau has served as our Chief Executive Officer and as a director since December 2012, and as our President since October 2012. Mr. Croteau joined us from NXP Semiconductors N.V. (“NXP”), a provider of mixed signal solutions and standard products, where he served as the Senior Vice President and General Manager of its High-Performance RF business from May 2008 to October 2012. For three of those years, Mr. Croteau also managed NXP’s Power & Lighting Solutions business. Prior to joining NXP, Mr. Croteau held numerous product management positions at Analog Devices, Inc. (“ADI”), a high-performance semiconductor company, including General Manager for ADI’s Convergent Platforms and Services Group as well as product line director for the Integrated Audio Group. Mr. Croteau holds a B.S. in Engineering Science and Mechanics from Penn State University. Mr. Croteau’s qualifications to serve as a director include his unique perspective and insights into our operations as our current President and Chief Executive Officer, including his knowledge of our products, technologies, business relationships, competitive and financial positioning, senior leadership and strategic opportunities and challenges. Our board of directors also benefits from Mr. Croteau’s industry perspective, stemming from his broad experience in a variety of executive roles at public semiconductor companies.





Charles Bland
Director




Charles Bland has served as a director since June 2016, and previously served as a director from December 2010 to February 2016. Mr. Bland served as our Chief Executive Officer from February 2011 to December 2012, and was employed by us in a transitional capacity following his retirement from service as our Chief Executive Officer through May 2013. Mr. Bland previously served as our Chief Operating Officer from June 2010 to February 2011. From April 2007 through December 2010, Mr. Bland served as a director and as the chairman of the audit committee of NightHawk Radiology Holdings, Inc. (“NightHawk”), a provider of teleradiology services. During 2009, Mr. Bland served as the Chief Financial Officer of American Gaming Systems, a privately-held designer, manufacturer and operator of gaming machines. Mr. Bland served as the Chief Financial Officer of Sirenza Microdevices, Inc. (“Sirenza”), a supplier of radio frequency semiconductors and related components for the commercial communications, consumer and aerospace, defense and homeland security equipment markets, from July 2005 through its sale to RF Micro Devices, Inc. (“RFMD”) in November 2007, and also as its Chief Operating Officer from May 2003 until July 2005. Mr. Bland received his B.S. in Accounting and Finance from The Ohio State University and his M.B.A. from the Sloan School, Massachusetts Institute of Technology. Mr. Bland’s qualifications to serve as a director include his detailed knowledge of our business, operations, senior leadership, and strategic opportunities and challenges based on his prior service as our Chief Executive Officer and Chief Operating Officer. In addition, Mr. Bland’s extensive experience in a variety of executive roles at public companies in our industry, his executive experience in other industries, and his prior experience as a public company director and audit committee chair allow him to bring a broad and diverse perspective to our board of directors. His prior Chief Financial Officer and audit committee experience have provided him expertise with accounting principles and financial reporting rules and regulations, in evaluating financial results and in generally overseeing the financial reporting process.

   Member of the Audit Committee
      

   Chair of the Nominating and Governance Committee
      





Peter Chung
Independent Director




Peter Chung has served as a director since December 2010. Mr. Chung is a Managing Director and the Chief Executive Officer of Summit Partners, L.P., which he joined in August 1994. Mr. Chung currently serves as a director and the chairman of the compensation committee of A10 Networks, Inc., a provider of application networking technologies, and as a director and chairman of the nominating and corporate governance committee of Acacia Communications, Inc., a provider of high-speed coherent optical interconnect products.  Mr. Chung has also served as a director of numerous other public companies, including, most recently, Ubiquiti, from March 2010 to October 2013, NightHawk, from March 2004 to December 2010, SeaBright Holdings, Inc., a provider of multi-jurisdictional workers’ compensation insurance and general liability insurance, from October 2003 to May 2010, and Sirenza, from October 1999 to April 2006. Mr. Chung also serves as a director of several privately-held companies. Mr. Chung received an A.B. from Harvard University and an M.B.A. from Stanford University. Mr. Chung is an experienced investor in market-leading growth companies. He contributes broad-based knowledge and experience in business strategy, capital markets and the communications technology and semiconductor industries. Mr. Chung provides valuable insight to our board of directors on all matters facing us, from operational to strategic. 

   Member of the Nominating and Governance Committee
      

   Chair of the Compensation Committee
      





Gil Van Lunsen
Independent Director




Gil Van Lunsen has served as a director since August 2010. Prior to his retirement in June 2000, Mr. Van Lunsen was a Managing Partner of KPMG LLP and led the firm’s Tulsa, Oklahoma office. During his 33-year career, Mr. Van Lunsen held various positions of increasing responsibility with KPMG LLP and was elected partner in 1977. Mr. Van Lunsen is currently a member of the board of directors and the audit committee chairman at Array Biopharma Inc., a biopharmaceutical company. He served as a director and the chairman of the audit committee of ONEOK Partners, L.P., a natural gas gathering, processing, storage and transportation provider and its predecessor entities from 2005 until his retirement in 2015. Previously, Mr. Van Lunsen served as a director of Sirenza and was chairman of its audit committee from October 2003 through its sale to RFMD in November 2007. Mr. Van Lunsen received a B.S./B.A. in accounting from the University of Denver. Mr. Van Lunsen has extensive experience with complex financial and accounting issues and, as a former partner of KPMG LLP and the audit committee chairman at other public companies in our industry and others, provides valuable leadership and insights to our board of directors on accounting, financial and governance matters. Having served as a director of Sirenza, Mr. Van Lunsen has also developed strong domain knowledge of the operational and financial issues facing our Company and our industry. 

   Chair of the Audit Committee
      

   Member of the Nominating and Governance Committee
      

   Member of the Compensation Committee
      





Susan Ocampo
Director




Susan Ocampo has served as a director since June 2016, and previously served as a director from December 2010 to February 2016. She has also served as Vice President, Secretary and Treasurer of GaAs Labs, LLC (“GaAs Labs”), a private investment fund targeting the communications semiconductor market, since co-founding it in February 2008. Previously, Mrs. Ocampo co-founded Sirenza in 1984. Mrs. Ocampo served as Sirenza’s Treasurer from November 1999 through its sale to RFMD in November 2007. Mrs. Ocampo holds a B.A. from Maryknoll College. Mrs. Ocampo’s extensive experience investing and serving in financial leadership roles with semiconductor companies strengthens our board of director’s oversight of our enterprise risk management, treasury functions and internal financial controls. We also believe that having our largest stockholder (together with Mr. Ocampo and their affiliates) on the board of directors assists the board in making decisions aimed at increasing stockholder value over the long term.





Stephen G. Daly
Director




Stephen G. Daly has served as a director since March 2015.  From January 2004 through March 2013, Mr. Daly served as the President of Hittite Microwave Corporation (“Hittite”), a provider of analog and mixed signal integrated circuits, modules and subsystems for commercial and military RF, microwave and millimeterwave applications. Mr. Daly also served as Hittite’s Chief Executive Officer from December 2004 through March 2013.  He served as a member of Hittite's board of directors from January 2004 through May 2013, and as its chairman from December 2005 through March 2013. From 1996 to 2004 he was employed in other application engineering, marketing and sales roles at Hittite. Mr. Daly also serves as a director of a privately-held company.  Mr. Daly received a B.S. in Electrical Engineering from Northeastern University.  Mr. Daly’s depth and breadth of expertise in the analog and mixed signal semiconductor industry and prior experience serving on the board of directors of a public company in our industry contributes valuable perspective and insight to our board of directors. 

   Member of the Audit Committee
      

   Member of the Compensation Committee
      





Geoffrey G. Ribar
Director




	Geoffrey G. Ribar, has served as a director since March 2017. Mr. Ribar has served as Senior Vice President and Chief Financial Officer of Cadence Design Systems, Inc., a provider of system design tools, software, intellectual property and services, since November 2010.   Previously, he served as Chief Financial Officer for a number of semiconductor companies, including Telegent Systems, Inc., SiRF Technology, Inc., Asyst Technology, Inc., Matrix Semiconductor, Inc. and nVidia Corporation. He received his B.S. degree in chemistry, and an M.B.A. from the University of Michigan. Mr. Ribar provides our board of directors with financial and accounting expertise based on his experience as a chief financial officer, as well as semiconductor industry expertise in areas ranging from global finance and mergers and acquisitions to investor relations.

   Member of the Audit Committee
      







Display all Bios


 

Audit


Nominating and Governance


Compensation




Charles Bland





Charles Bland
Director 
Charles Bland has served as a director since June 2016, and previously served as a director from December 2010 to February 2016. Mr. Bland served as our Chief Executive Officer from February 2011 to December 2012, and was employed by us in a transitional capacity following his retirement from service as our Chief Executive Officer through May 2013. Mr. Bland previously served as our Chief Operating Officer from June 2010 to February 2011. From April 2007 through December 2010, Mr. Bland served as a director and as the chairman of the audit committee of NightHawk Radiology Holdings, Inc. (“NightHawk”), a provider of teleradiology services. During 2009, Mr. Bland served as the Chief Financial Officer of American Gaming Systems, a privately-held designer, manufacturer and operator of gaming machines. Mr. Bland served as the Chief Financial Officer of Sirenza Microdevices, Inc. (“Sirenza”), a supplier of radio frequency semiconductors and related components for the commercial communications, consumer and aerospace, defense and homeland security equipment markets, from July 2005 through its sale to RF Micro Devices, Inc. (“RFMD”) in November 2007, and also as its Chief Operating Officer from May 2003 until July 2005. Mr. Bland received his B.S. in Accounting and Finance from The Ohio State University and his M.B.A. from the Sloan School, Massachusetts Institute of Technology. Mr. Bland’s qualifications to serve as a director include his detailed knowledge of our business, operations, senior leadership, and strategic opportunities and challenges based on his prior service as our Chief Executive Officer and Chief Operating Officer. In addition, Mr. Bland’s extensive experience in a variety of executive roles at public companies in our industry, his executive experience in other industries, and his prior experience as a public company director and audit committee chair allow him to bring a broad and diverse perspective to our board of directors. His prior Chief Financial Officer and audit committee experience have provided him expertise with accounting principles and financial reporting rules and regulations, in evaluating financial results and in generally overseeing the financial reporting process.










        
           
        
      



Peter Chung





Peter Chung
Independent Director 
Peter Chung has served as a director since December 2010. Mr. Chung is a Managing Director and the Chief Executive Officer of Summit Partners, L.P., which he joined in August 1994. Mr. Chung currently serves as a director and the chairman of the compensation committee of A10 Networks, Inc., a provider of application networking technologies, and as a director and chairman of the nominating and corporate governance committee of Acacia Communications, Inc., a provider of high-speed coherent optical interconnect products.  Mr. Chung has also served as a director of numerous other public companies, including, most recently, Ubiquiti, from March 2010 to October 2013, NightHawk, from March 2004 to December 2010, SeaBright Holdings, Inc., a provider of multi-jurisdictional workers’ compensation insurance and general liability insurance, from October 2003 to May 2010, and Sirenza, from October 1999 to April 2006. Mr. Chung also serves as a director of several privately-held companies. Mr. Chung received an A.B. from Harvard University and an M.B.A. from Stanford University. Mr. Chung is an experienced investor in market-leading growth companies. He contributes broad-based knowledge and experience in business strategy, capital markets and the communications technology and semiconductor industries. Mr. Chung provides valuable insight to our board of directors on all matters facing us, from operational to strategic. 




        
           
        
      









Gil Van Lunsen





Gil Van Lunsen
Independent Director 
Gil Van Lunsen has served as a director since August 2010. Prior to his retirement in June 2000, Mr. Van Lunsen was a Managing Partner of KPMG LLP and led the firm’s Tulsa, Oklahoma office. During his 33-year career, Mr. Van Lunsen held various positions of increasing responsibility with KPMG LLP and was elected partner in 1977. Mr. Van Lunsen is currently a member of the board of directors and the audit committee chairman at Array Biopharma Inc., a biopharmaceutical company. He served as a director and the chairman of the audit committee of ONEOK Partners, L.P., a natural gas gathering, processing, storage and transportation provider and its predecessor entities from 2005 until his retirement in 2015. Previously, Mr. Van Lunsen served as a director of Sirenza and was chairman of its audit committee from October 2003 through its sale to RFMD in November 2007. Mr. Van Lunsen received a B.S./B.A. in accounting from the University of Denver. Mr. Van Lunsen has extensive experience with complex financial and accounting issues and, as a former partner of KPMG LLP and the audit committee chairman at other public companies in our industry and others, provides valuable leadership and insights to our board of directors on accounting, financial and governance matters. Having served as a director of Sirenza, Mr. Van Lunsen has also developed strong domain knowledge of the operational and financial issues facing our Company and our industry. 















Stephen G. Daly





Stephen G. Daly
Director 
Stephen G. Daly has served as a director since March 2015.  From January 2004 through March 2013, Mr. Daly served as the President of Hittite Microwave Corporation (“Hittite”), a provider of analog and mixed signal integrated circuits, modules and subsystems for commercial and military RF, microwave and millimeterwave applications. Mr. Daly also served as Hittite’s Chief Executive Officer from December 2004 through March 2013.  He served as a member of Hittite's board of directors from January 2004 through May 2013, and as its chairman from December 2005 through March 2013. From 1996 to 2004 he was employed in other application engineering, marketing and sales roles at Hittite. Mr. Daly also serves as a director of a privately-held company.  Mr. Daly received a B.S. in Electrical Engineering from Northeastern University.  Mr. Daly’s depth and breadth of expertise in the analog and mixed signal semiconductor industry and prior experience serving on the board of directors of a public company in our industry contributes valuable perspective and insight to our board of directors. 







        
           
        
      






Geoffrey G. Ribar





Geoffrey G. Ribar
Director 
	Geoffrey G. Ribar, has served as a director since March 2017. Mr. Ribar has served as Senior Vice President and Chief Financial Officer of Cadence Design Systems, Inc., a provider of system design tools, software, intellectual property and services, since November 2010.   Previously, he served as Chief Financial Officer for a number of semiconductor companies, including Telegent Systems, Inc., SiRF Technology, Inc., Asyst Technology, Inc., Matrix Semiconductor, Inc. and nVidia Corporation. He received his B.S. degree in chemistry, and an M.B.A. from the University of Michigan. Mr. Ribar provides our board of directors with financial and accounting expertise based on his experience as a chief financial officer, as well as semiconductor industry expertise in areas ranging from global finance and mergers and acquisitions to investor relations.







        
           
        
      

        
           
        
      



 = Chair
     = Member
    = Independent Director
    


















About MACOM
MACOM Technology Solutions Holdings, Inc. (www.macom.com) supplies
                                            key
                                            enabling technologies for the Cloud Connected Apps Economy and
                                            Modern
                                            Networked Battlefield.
Learn
                                            More











Corporate Documents





Corporate Presentation




Cloud Data Center Forum Slides




Preliminary Injunction Order




AppliedMicro Acquisition Slides




MACOM Analyst Day Presentation




Non-GAAP Proforma Data for Auto Sale




Aeroflex/Metelics Acquisition Slides




FiBest Acquisition Slides




BinOptics Acquisition Presentation




Mindspeed Acquisition Slides












Shareholder Tools

 Shareholder Briefcase



                Corporate Presentation
              


 Download Library
Snapshot
 RSS Feeds












@MACOMtweets
Tweets by
                                    @MACOMtweets














Stock Quote (NASDAQ:MTSI)



Price:
62.84


Change:
+0.11


Day High:
63.46


Day Low:
61.99


Volume:
283,867



1:36 PM ET on Jul 21, 2017
Delayed at least 20 minutes. Provided by eSignal









Investor Relations
News & Events

News Releases
Events & Webcasts


Corporate Governance

Leadership
Board of Directors
Committee Composition
Governance Documents


Financial Information

Financial Reports
SEC Filings
IRS Forms


Stock Information

Analyst Coverage

Investor FAQ's

Request Information

Email Alerts
Investor Contacts










Events & Webcasts


Aug 1, 2017 at 5:00 PM ET
MACOM Technology Solutions Third Quarter Fiscal  2017 Financial Results Conference Call


View all events & webcasts »












Products


RF Power Products


Optoelectronics


Photonic Solutions


Optical Sub-Assemblies


Amplifiers


Diodes


Crosspoints and Signal Conditioners


SDI Products


Frequency Conversion


Control Products


Passives


HDcctv Devices


Frequency Generation


Communications Processors


Hi-Rel Components







Applications


Wireless Networking and Communication


Optical Networking


RF Energy


Aerospace and Defense


Industrial, Scientific and Medical


Wired Broadband


Broadcast Video


Enterprise Solutions


Surveillance







About MACOM



    Investors



In the Community


News and Events


Careers


Quality & Reliability


Virtual Patent Marking


Foundry



    California Transparency in Supply Chains Act








Support


Training


RF & Microwave Product Selection Guide


Contact Us


Key Markets & Products Brochure


Technical Resources Library


Optoelectronics & Photonics Portfolio


High Power GaN Portfolio


SDI Video Portfolio


Diodes Portfolio


Space & High-Reliability Portfolio








© 2017 MACOM All Rights Reserved






SiteMap
 | 
Privacy Policy
 | 
Terms Of Use














































 
Array Biopharma Inc (ARRY.O)  People | Reuters.com


























































X



Edition:

United States


















Africa
América Latina


عربي
Argentina


Brasil
Canada


中国
Deutschland


España
France


India
Italia


日本
México


РОССИЯ
United Kingdom

United States
















Array Biopharma Inc (ARRY.O)










Related Topics: 
StocksStock ScreenerMarket DataHealthcareBiotechnology & Medical Research












                
                        Overview
                    



                
                        News
                    



                
                        Key Developments
                    



                
                        People
                    



                
                        Charts
                    



                
                        Financials
                    



                
                        Analysts
                    



                    
                            Research
                        



                    
                            Pulse
                        










				ARRY.O on Consolidated Issue listed on NASDAQ Global Market


				8.18USD
21 Jul 2017





				    Change	(% chg)


		    
						    $-0.20


					            (-2.39%)
					        






Prev Close

$8.38


Open

$8.48




Day's High

$8.49


Day's Low

$8.16




Volume

1,169,003


Avg. Vol

3,614,056




52-wk High

$13.40


52-wk Low

$3.10











					Summary





Name
Age
Since
Current Position




							Kyle Lefkoff

56
2012

                                Independent Chairman of the Board




							Ron Squarer

50
2012

                                Chief Executive Officer, Director




							Jason Haddock

46
2016

                                Chief Financial Officer




							Andrew Robbins

40
2015

                                Chief Operating Officer




							Nicholas Saccomano

57
2014

                                Chief Scientific Officer




							John Moore

52
2002

                                Vice President, General Counsel, Secretary




							Victor Sandor

50
2014

                                Chief Medical Officer




							Shalini Sharp

42
2017

                                Director




							Charles Baum

58
2014

                                Independent Director




							Gwendolyn Fyfe

64
2012

                                Independent Director




							John Orwin

52
2012

                                Independent Director




							Gil Van Lunsen

74
2002

                                Independent Director




							Tricia Haugeto


2016

                                Director, Corporate Communications and Investor Relations



» Insider Trading





					Biographies





Name
Description




							Kyle Lefkoff


					
							Mr. Kyle A. Lefkoff is an Independent Chairman of the Board of Array Biopharma Inc. From January 2012 through April 2012, Mr. Lefkoff served as our interim Executive Chairman following the resignation of our former Chief Executive Officer, Mr. Robert E. Conway, in January 2012. When our current Chief Executive Officer, Mr. Ron Squarer, was hired in April 2012, Mr. Lefkoff stepped down as Executive Chairman and resumed his position as Chairman of our Board of Directors. Since 1995, Mr. Lefkoff has been a General Partner of Boulder Ventures, Ltd, a venture capital firm and a founding investor in our company. From 1986 until 1995, Mr. Lefkoff was employed by Colorado Venture Management, a venture capital firm. Mr. Lefkoff serves on the board of directors for a number of private companies, including: miRagen Therapeutics, Market Force Information and CommercialTribe, Inc.




							Ron Squarer


					
							Mr. Ron Squarer serves as Chief Executive Officer, Director of Array BioPharma Inc. Prior to Array, Prior to Array, Mr. Squarer served as Senior Vice President, Chief Commercial Officer at Hospira Inc., a global pharmaceutical and medical device company, from February 2010 to April 2012, where he was responsible for delivering $4 billion in annual revenue and leading more than 2,000 employees worldwide. From 2009 to 2010, Mr. Squarer was responsible for strategy, new product development and commercialization, acquisitions, partnerships and portfolio prioritization as Senior Vice President, Global Marketing and Corporate Development and held a similar role focused on Strategy and Business Development from 2007 to 2008. Mr. Squarer joined Hospira from Mayne Pharma, an Australia-based specialty injectable pharmaceutical company, where he served as Senior Vice President, Global Corporate and Business Development from 2006 to 2007, when Mayne was sold to Hospira for $2 billion in 2007. Prior to 2007, Mr. Squarer held senior management roles at both Pfizer, Inc., focused on global oncology commercial development, and at SmithKline Beecham Pharmaceuticals (now GlaxoSmithKline) in the U.S. and Europe.




							Jason Haddock


					
							Mr. Jason Haddock is Chief Financial Officer of the Company. From November 2011 to January 2015, Mr. Haddock held leadership positions of increasing responsibility at Bristol-Myers Squibb, in a variety of accounting, planning, commercial, analytical and business development capacities for high-growth business units, including Head of Finance for the Worldwide Commercialization and Medical divisions. Mr. Haddock has served as CFO and COO for high-growth business units in Asia Pacific, Europe and the United States. He mostly recently served as CFO and COO at BERG Health, a privately held Boston biopharmaceutical company from June 2015 to July 2016.




							Andrew Robbins


					
							Mr. Andrew R. Robbins is Chief Operating Officer of Company. From July 2012, he was our Senior Vice President, Commercial Operations. Mr. Robbins has extensive commercial, development and strategic leadership expertise from a 15-year career in the pharmaceutical industry, with a specific focus on oncology/hematology products. From January 2007 to July 2012, he held management positions at Hospira, Inc., a global pharmaceutical and medical device company, including General Manager/Vice President of the U.S. Alternate Site business unit and Vice President of Corporate Development. Prior to joining Array, Mr. Robbins also served on the board of directors of Fate Therapeutics, Cytograft and StemCor Systems, all venture-backed health care companies. Prior to January 2007 he held commercial leadership positions within Pfizer's oncology unit.




							Nicholas Saccomano


					
							Dr. Nicholas A. Saccomano, Ph.D., is Chief Scientific Officer of the Company. He has 30 years of experience in pharmaceutical and biotechnology research and development, with expertise in discovery research, clinical development, portfolio strategy, technology and clinical candidate licensing, and scientific partnering. Dr. Saccomano most recently served as Chief Technology Officer at SomaLogic, Inc., headquartered in Boulder, Colorado, from January 2010 to May 2014 and as a consultant for SomaLogic from June 2009 to December 2009. Prior to joining Somalogic, Dr. Saccomano served as Chief Scientific Officer at Bend Research Inc., headquartered in Bend, Oregon, from May 2008 to December 2008, and as a consultant for Bend Research from January 2009 to December 2009 and continued on their board of directors until October 2013. Dr. Saccomano also held positions of increasing responsibility at Pfizer, Inc. from December 1984 to May 2008, including Senior Vice President in the R&D organization and Vice President of Discovery Technology. As head of discovery technology, he managed and developed a diverse set of enabling technologies used broadly across the drug discovery pipeline. During his tenure at Pfizer, he also directed medicinal sciences, drug discovery and strategic alliances.




							John Moore


					
							Mr. John R. Moore is Vice President, General Counsel, Secretary of Array Biopharma Inc. Prior to joining Array, Mr. Moore was an associate for three years with the law firm of Wilson Sonsini Goodrich & Rosati where he negotiated transactions involving technology, intellectual property and products. From September 1992 to July 1996, and August 1996 to June 1999, Mr. Moore was an associate with the law firms of Kenyon & Kenyon and Arnold White & Durkee, respectively, where he focused on intellectual property matters. He currently serves on the Board of Directors of Nivalis Therapeutics, Inc., a public company.




							Victor Sandor


					
							Dr. Victor Sandor M.D. has been appointed as Chief Medical Officer of the Company. Prior to joining Array, Dr. Sandor was Senior Vice President for Global Clinical Development at Incyte Corporation, a position he held beginning May 2014 after first joining Incyte in February 2010 as its Vice President Global Oncology Drug Development. Prior to joining Incyte, Dr. Sandor was Vice President and Chief Medical Officer for oncology at Biogen Idec from November 2009 to February 2010. He previously held positions of increasing responsibility in oncology product development at AstraZeneca from September 2002 to November 2009, where he played an important role in the registration of Arimidex for adjuvant use, the development of Faslodex, and the development of several early stage programs through proof of concept.




							Shalini Sharp


					
							Ms. Shalini Sharp has been appointed as Director of the Company., effective April 27, 2017. Ms. Sharp has served as Chief Financial Officer of Ultragenyx Pharmaceutical, Inc., a publicly-traded biopharmaceutical company focused on rare diseases, since 2012, where she is responsible for leading the corporate finance, strategy, and information technology functions and is a member of the company’s executive leadership team. Ms. Sharp is also a member of the Board of Directors of Agenus Inc. (formerly Antigenics Inc.), a publicly traded immuno-oncology company, where she served as Chief Financial Officer from 2006 to 2012. She joined Agenus in 2003 and held increasing roles of responsibility spanning strategic planning, corporate development, investor relations, corporate finance and business development. She is also a member of the Board of Directors of the TB Alliance, a non-profit organization dedicated to the development and distribution of treatments for tuberculosis in the developing world. Prior to Agenus, Ms. Sharp held similar roles at Elan Pharmaceuticals from 1998 to 2003, including serving as chief of staff to the Chairman of the Board of Directors during that company's restructuring. She has spearheaded numerous financing and business development transactions that were critical to the success of Agenus and Elan. Ms. Sharp was also a management consultant at McKinsey & Company as well as an investment banker at Goldman Sachs, specializing in pharmaceuticals and medical devices. Ms. Sharp holds both a B.A., magna cum laude, and a M.B.A. from Harvard University.




							Charles Baum


					
							Dr. Charles M. Baum M.D., Ph.D. is an Independent Director of the Company. Dr. Baum has served as the President and Chief Executive Officer of Mirati Therapeutics since 2012. Prior to joining Mirati, Dr. Baum had worked at Pfizer since 2003, most recently as the Senior Vice President for Clinical Research within Pfizer's Worldwide Research & Development division. At Pfizer, Dr. Baum held roles of increasing responsibility, including Vice President and Head of Oncology Development and Chief Medical Officer for Pfizer's Biotherapeutics and Bioinnovation Center, a Pfizer division comprised of small biotech research units. During his tenure at Pfizer he was responsible for the development of the company’s oncology portfolio, including the tyrosine kinase inhibitors Sutent® (sunitinib), Inlyta® (axitinib) and Xalkori® (crizotinib). Prior to joining Pfizer, Dr. Baum was responsible for the Phase I-IV development of several oncology compounds at Schering-Plough, including Temodar® (temozolomide).




							Gwendolyn Fyfe


					
							Dr. Gwendolyn A. Fyfe M.D. is an Independent Director of the Company. From 1997 to 2009, Dr. Fyfe held various positions with Genentech Inc. (now a member of the Roche Group), including Vice President, Oncology Development; Vice President, Avastin® Franchise Team; as well as the honorary title of Senior Staff Scientist. Dr. Fyfe played an important role in the development of Genentech's approved oncology agents including Rituxan®, Herceptin®, Avastin® and Tarceva®. Dr. Fyfe sat on the development oversight committee for all of Genentech's products and participated in the Research Review Committee that moved products from research into clinical development. Since leaving Genentech in 2009, Dr. Fyfe has been a consultant for venture capital firms and for a variety of biotechnology companies. Dr. Fyfe serves as a director of publicly-traded Infinity Pharmaceuticals and Igenica Biotherapeutics, a private company. Dr. Fyfe is a recognized oncology expert in the broader oncology community and has been an invited member of Institute of Medicine panels, National Cancer Institute working groups and grant committees and American Society of Clinical Oncologists oversight committees.




							John Orwin


					
							Mr. John A. Orwin is an Independent Director of Array Biopharma Inc. He became Chief Executive Officer of Relypsa, Inc. in June 2013. From February 2011 to May 2013, Mr. Orwin served as Chief Executive Officer of Affymax, Inc., which he joined in April 2010 as President and Chief Operating Officer. From January 2005 to April 2010, Mr. Orwin served at Genentech, where he served as Senior Vice President, BioOncology Business Unit since 2007. From 2001 to 2004, Mr. Orwin served in various executive level positions at Johnson & Johnson. Prior to that Mr. Orwin was Senior Director, Oncology Marketing at ALZA Pharmaceuticals (acquired by Johnson & Johnson); Vice President, Marketing at Sangstat Medical Corporation; Marketing Director, Asthma at Rhone-Poulenc Rorer Pharmaceuticals and Product Manager, Schering Oncology/Biotech at Schering-Plough Corporation. Mr. Orwin serves on the board of directors of publicly-traded Relypsa, Inc. and Seattle Genetics, Inc.




							Gil Van Lunsen


					
							Mr. Gil J. Van Lunsen is an Independent Director of Array Biopharma Inc. Prior to his retirement in June 2000, Mr. Van Lunsen was an Office Managing Partner of KPMG LLP and led the firm's Tulsa, Oklahoma office. During his 33-year career, Mr. Van Lunsen held various positions of increasing responsibility within KPMG and was elected to the partnership in 1977. Until April 2015, Mr. Van Lunsen was the Chairman of both the Audit Committee and the Conflicts Committee at ONEOK Partners, GP, L.L.C. in Tulsa, Oklahoma. Additionally, Mr. Van Lunsen is currently the Audit Committee Chairman and a member of the Governance Committee and Compensation Committee at M/A-Com Technology Solutions, Inc. in Lowell, Massachusetts.




							Tricia Haugeto














					Basic Compensation





Name
Fiscal Year Total




							Kyle Lefkoff

192,043




							Ron Squarer

1,980,070




							Jason Haddock

--




							Andrew Robbins

1,164,680




							Nicholas Saccomano

--




							John Moore

904,218




							Victor Sandor

1,126,530




							Shalini Sharp

--




							Charles Baum

148,043




							Gwendolyn Fyfe

156,043




							John Orwin

147,793




							Gil Van Lunsen

153,293




							Tricia Haugeto

--



As Of 
29 Jun 2016





					Options Compensation





Name
Options
Value




							Kyle Lefkoff

0
0




							Ron Squarer

0
0




							Jason Haddock

0
0




							Andrew Robbins

0
0




							Nicholas Saccomano

0
0




							John Moore

169,727
238,530




							Victor Sandor

0
0




							Shalini Sharp

0
0




							Charles Baum

0
0




							Gwendolyn Fyfe

0
0




							John Orwin

0
0




							Gil Van Lunsen

0
0




							Tricia Haugeto

0
0









					Insider Trading












Name
Shares Traded
Price


Sandor (Victor)
7,303
$8.94


Saccomano (Nicholas A)
6,875
$0.00


Squarer (Ron R)
18,906
$0.00


Saccomano (Nicholas A)
4,535
$8.94


Moore (John R)
4,408
$8.94


Moore (John R)
6,718
$0.00


Robbins (Andrew R.)
9,167
$8.94


Robbins (Andrew R.)
9,843
$0.00


Sandor (Victor)
7,812
$0.00


Squarer (Ron R)
17,563
$8.94


Lefkoff (Kyle A)
25,000
$3.69


Lefkoff (Kyle A)
20,000
$4.36


Lefkoff (Kyle A)
45,000
$8.92


Baum (Charles M)
25,000
$9.27


Baum (Charles M)
25,000
$3.87


Lefkoff (Kyle A)
2,000
$0.00


Baum (Charles M)
5,000
$5.83


Van Lunsen (Gil J)
5,000
$0.00


Orwin (John A)
5,000
$0.00


Fyfe (Gwen A)
5,000
$5.83


Lefkoff (Kyle A)
5,000
$0.00


Redmile Group, L.L.C.
2,492,578
$6.36


Sandor (Victor)
95,890
$0.00


Sandor (Victor)
31,117
$3.69


Redmile Group, L.L.C.
28,000
$3.50




» Full list on Insider Trading
















Related Topics: 
StocksStock ScreenerMarket DataHealthcareBiotechnology & Medical Research




















